DOSSIER · 13F Holders · Q2 2026
TCRX
TSCAN THERAPEUTICS INC
64 institutions still hold TSCAN THERAPEUTICS INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 89854M101·64 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
64 institutions reported TCRX in Q2 2026. Lynx1 Capital Management LP leads at 25.2% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 4
44 more holders available. Log in →